NCT06939764

Application of the sG8 Scale in Real-World Geriatric Oncology Patients

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 346 (estimated)
• Sponsor: Sichuan Cancer Hospital and Research Institute · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

This study is a multicenter, prospective, observational study. The study included patients aged 65 and older with solid tumors requiring systemic anti-tumor therapy. All patients underwent screening using the sG8 scale before the start of treatment, followed by routine treatment based on a plan developed through clinician decision-making. The study did not intervene in any way with the patients' diagnosis and treatment, and relevant clinical data during the treatment process were recorded accurately for follow-up patients. Study data were obtained from the electronic medical record databases and hospital information systems of multiple centers, including Sichuan Cancer Hospital. Patient clinicopathological features, pathological diagnoses, clinical stages, previous treatment histories, as well as anti-tumor treatment regimens after patient enrollment, drug dosages per cycle, treatment start times, incidence and grades of adverse events (AEs), and tumor response were extracted and collected from the medical records. All data were entered, managed, quality-controlled, exported, and analyzed through a real-world data management platform (RWDMP).

Conditions

• Solid Cancers
• Geriatric Assessment

Interventions

Type	Name	Description
OTHER	Geriatric Screening using the sG8 scale	Geriatric screening using the sG8 scale

Timeline

• Start date: 2025-05-16
• Primary completion: 2025-12-25
• Completion: 2026-04-30
• First posted: 2025-04-23
• Last updated: 2025-04-23